Analyst picks & changes
Piper Jaffray analyst Barbara Hoffman said she is enthusiastic about three cystic fibrosis therapies — Genentech Inc.'s
DNase,
Gathering data...
Piper Jaffray analyst Barbara Hoffman said she is enthusiastic about three cystic fibrosis therapies — Genentech Inc.'s
DNase,